cannabis investing Canntab and Emblem Announce Positive Results on Testing: Proceeding to Clinical Trials
cannabis investing Emblem and Canntab to Commence Clinical Testing of 12-Hour Extended Release Cannabis Tablets
cannabis investing Emblem Signs Supply Agreement with Aphria to Purchase up to 175,000 kg Equivalents of Cannabis Products Over Five Years
cannabis investing UPDATE: Emblem Signs Five-Year Supply Agreement with Compass Cannabis Clinic for Starbuds Canada
